Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
971.15%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 23.01Close
$ 11.02 - $ 25.71 52-Week Range
Ticker Information
Ticker
VRDNCompany Name
VIRIDIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIRIDIAN THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRDN - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.96M | 971.15% | $ 305K |
| 3/31/2025 | $ 3.04M | 1008.28% | $ 302K |
| 12/31/2024 | $ 3.05M | 1008.61% | $ 302K |
| 9/30/2024 | $ 3.1M | 1027.81% | $ 302K |
| 6/30/2024 | $ 2.7M | 937.5% | $ 288K |
| 3/31/2024 | $ 2.27M | 787.85% | $ 288K |
| 12/31/2023 | $ 1.85M | 588.22% | $ 314K |
| 9/30/2023 | $ 1.1M | 316.71% | $ 347K |
| 6/30/2023 | $ 663K | 45.1% | $ 1.47M |
| 3/31/2023 | $ 651K | 39.36% | $ 1.65M |
Key Performance Insights, Last 5 Years
- VIRIDIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 26.55%.
- Over the past 5 years, VIRIDIAN THERAPEUTICS INC's average Int. Exp. % has been 345.34%.
- The median Int. Exp. % for VIRIDIAN THERAPEUTICS INC during this period was 42.23%
- VIRIDIAN THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 1027.81%.
- The lowest Int. Exp. % recorded by VIRIDIAN THERAPEUTICS INC in the same timeframe 0.1%
VIRIDIAN THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for VIRIDIAN THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 498K ] / Revenues [ $ 1.88M ]
(=) Int. Exp. % [ 26.55% ] VRDN - Interest Expense Margin, Last 5 years
0.1%
Minimum
Dec 31, 2021
1027.81%
Maximum
Sep 30, 2024
345.34%
Average
42.23%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |